+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 18Years +
All Genders
ID06631287

Evaluating Baricitinib Versus Placebo for Persistent Neurologic and Cardiopulmonary Symptoms in Long COVID

Led by Wes Ely · Updated on 2026-09-25

550

Participants Needed

17

Research Sites

34 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating the effects of baricitinib compared to a placebo on neurocognitive function and physical symptoms in adults with Long COVID. This study focuses on persistent neurological and cardiopulmonary symptoms such as brain fog, breathlessness, and fatigue that continue for months after initial COVID-19 infection. The trial aims to better understand improvements in quality of life, symptom burden, and biomarkers related to inflammation and viral activity in this population. Participants are randomly assigned to receive either baricitinib, a Janus kinase inhibitor taken as a 4mg oral tablet once daily, or a matched placebo pill for 24 weeks. The study is double-blind and placebo-controlled, ensuring that neither participants nor researchers know which treatment is given. The trial includes detailed monitoring of cognitive and physical function, symptom questionnaires, and laboratory tests over a 12-month period. During the study, participants will undergo assessments including neuropsychological tests, exercise capacity evaluations, quality of life questionnaires, and measurements of breathlessness and post-exertional malaise at various time points up to one year. Safety and symptom changes will be closely monitored, and blood samples will be collected for biomarker analysis. Overall participation may last over a year, with key outcomes measured at 6 and 12 months after treatment begins.

CONDITIONS

Brief Title

Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID

Research Team

A

Amanda Bistran-Hall

W

Wes Ely, M.D.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here